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Abstract
Squalamine, an aminosterol antibiotic isolated from the dogfish shark, creates relatively large defects in phospholipid
bilayers, allowing the unrestricted translocation of small molecules across these compromised membranes (B.S. Selinsky, Z.
Zhou, K.G. Fotjik, S.R. Jones, N.R. Dollahon, A.E. Shinnar, Biochim. Biophys. Acta 1370 (1998) 218^234). However, an
aminosterol structurally similar to squalamine was found to act as a proton ionophore in anionic phospholipid vesicles. In
contrast with squalamine, gross membrane disruption was not observed with this synthetic analog (G. Deng, T. Dewa, S.L.
Regen, J. Am. Chem. Soc. 118 (1996) 8975^8976). In this report, the ionophoric activity of squalamine was tested in anionic
and zwitterionic phospholipid vesicles. No ionophoric activity was observed for squalamine in vesicles comprised of
phosphatidylglycerol (PG), phosphatidylcholine (PC), or a mixture of the two lipids. Experiments using radiolabeled
squalamine indicated that all of the squalamine added to PG vesicles remained with the vesicles, while approximately one-
half of the squalamine added to PC vesicles was incorporated. We have synthesized the aminosterol analog of squalamine
possessing ionophoric activity, and its ionophoric activity in PG vesicles was confirmed. The synthetic compound possessed
no measurable lytic activity when added to preformed phospholipid vesicles. As both compounds possess significant
antimicrobial activity, these results suggest that either multiple mechanisms for the antimicrobial activity of aminosterols
exist, depending upon the aminosterol structure, or possibly an unrelated common mechanism for antimicrobial activity
remains to be discovered. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Squalamine is a novel aminosterol sulfate isolated
from the liver of the dog¢sh shark [1]. The structure
of squalamine (shown in Fig. 1) has been determined
by NMR spectroscopy, mass spectroscopy, and by
synthesis of the authentic compound [2^4]. Squal-
amine exhibits antimicrobial activity against a wide
variety of microorganisms [1]. Squalamine also dem-
onstrates promise as an antiangiogenic agent, pre-
venting the formation of new blood vessels in devel-
oping malignant tumors [5].
A large number of aminosterols similar to squal-
amine have been synthesized and tested for antimi-
crobial activity [6^9]. While in our measurements
squalamine remains the most e¡ective antimicrobial
agent, many similar compounds also exhibit signi¢-
cant activity. The minimum structural requirements
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for antimicrobial activity appear to be a steroid ring
(or other similar large hydrophobic backbone) to
which is attached an amine at one site and some
type of charged or polar group (carboxylic acid, car-
boxylic acid ester, or sulfate group) at a second site.
Antimicrobial activity is modi¢ed by the nature of
the acidic group, the length, charge, and structure of
the amine or polyamine group, and the addition of
hydroxyl substituents to the steroid ring. However,
the existence of antimicrobial activity seems to re-
quire only the presence of the requisite components,
and not their precise location.
When added externally to preformed phospholipid
vesicles, squalamine e¡ects the leakage of £uorescent
dyes entrapped within the vesicles [10]. Defects of
approx. 2 nm in diameter are formed when squal-
amine is added to vesicles. Signi¢cant morphological
changes in phospholipid vesicles are induced by the
addition of squalamine. Based upon these and other
experiments, a model to explain the antimicrobial
activity of squalamine was proposed. In this model,
squalamine interacts with acidic phospholipids in mi-
crobial membranes, forming squalamine/phospholip-
id aggregates. These aggregates disrupt the mem-
brane and form transient defects, allowing the
translocation of materials across the membrane. If
the defect persists, the cell loses signi¢cant resources
and dies.
Regen’s group has synthesized an aminosterol with
potent antimicrobial activity structurally di¡erent
from the types synthesized in our laboratory [8].
The structure of the aminosterol synthesized by Re-
gen’s group (hereafter referred to as compound 1) is
given in Fig. 1. Compound 1, when incorporated
into large unilamellar phospholipid vesicles during
their preparation, acts as a proton ionophore in
anionic phospholipid membranes [11]. No ionophor-
ic activity is observed when the compound is incor-
porated into zwitterionic phosphatidylcholine mem-
branes. Based upon these observations, Regen
proposed that squalamine acts as a proton iono-
phore, dissipating the proton gradient across bacte-
rial membranes and disabling ATP synthesis in bac-
terial cells, resulting in cell death.
In this paper, the ionophoric model for the anti-
microbial activity of squalamine was tested. No iono-
phoric activity was found for squalamine under a
variety of di¡erent assay conditions. We have syn-
thesized compound 1, and have con¢rmed the iono-
phoric activity of this material. In contrast with
squalamine, compound 1 is not lytic when tested
against anionic or zwitterionic phospholipid vesicles.
These results indicate that small di¡erences in struc-
ture may lead to vastly di¡erent ways in which ami-
nosterols interact with membranes. Multiple mecha-
nisms for antimicrobial activity may exist, or a
mechanism not yet explored might be possible.
2. Methods
2.1. Chemicals
Egg yolk phosphatidylcholine (PC), phosphatidyl-
glycerol derived from egg yolk PC (PG), and 1-pal-
mitoyl-2-oleoylphosphatidylglycerol (POPG) were
purchased from Avanti Polar Lipids (Alabaster,
AL). 1-Hydroxypyrene-3,6,8-trisulfonic acid (HPTS)
and p-xylene-bis-pyridinium bromide (DPX) were
purchased from Molecular Probes (Eugene, OR).
Calcein was purchased from Fluka (Ronkonkoma,
NY) and puri¢ed by Sephadex LH-20 column chro-
matography [12].
Squalamine was isolated from the liver of the
shark Squalus acanthias as previously described [1],
and puri¢ed at the tri£uoroacetate salt. The squal-
amine analog 1 (Fig. 1) was synthesized essentially as
described [8]. The identity of the squalamine analog
was con¢rmed by NMR spectroscopy, mass spectros-
copy, and CHN elemental analysis, which agreed
with published values [8] within experimental error.
Tritiated squalamine was the kind gift of Dr. William
Kinney of Magainin Pharmaceuticals.
Fig. 1. The structures of the aminosterols used in this study.
Squalamine is the naturally occurring compound isolated from
the shark, while compound 1 is a synthetic analog.
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2.2. Measurements of ionophoric activity
Large unilamellar vesicles (LUVs) were prepared
by extrusion [13] in the presence of HPTS. Five milli-
grams of phospholipid (PC, PG, POPG, or a 7/3
mixture of PC/PG) were suspended in 2/1 chloro-
form/methanol. When desired, a small aliquot of ei-
ther squalamine or compound 1, dissolved in meth-
anol, was added to the lipid solution. The organic
solvent was removed under a stream of nitrogen gas,
and then under vacuum for at least 2 h. The dry lipid
was resuspended into 0.5 ml of bu¡er (25 mM
HEPES, 50 mM NaCl, 0.1 mM HPTS, pH 7.0), sub-
jected to ten freeze-thaw cycles, and then extruded 29
times through a 100 nm polycarbonate ¢lter. Exter-
nal HPTS was removed by passage over a (1U15 cm)
Sephadex G-75 column, eluting with the same bu¡er
without HPTS. Harvested vesicles were stored on ice
and used the same day of preparation.
To test for ionophoric activity, an aliquot of
vesicles (20^200 Wl) containing encapsulated HPTS
at pH 7.0 was added to a cuvette containing 3.0 ml
of bu¡er (25 mM HEPES, 50 mM NaCl, pH 8.0)
maintained at 25‡C. The £uorescence of HPTS
(Vex = 469 nm; Vem = 508 nm) was monitored as a
function of time on a Quantamaster £uorescence
spectrometer (Photon Technologies, Princeton, NJ).
The £uorescence intensity of HPTS is a linear func-
tion of pH in the range between pH 7.0 and 8.0 (Fig.
2). The increase in £uorescence intensity after addi-
tion of vesicles to pH 8.0 bu¡er is interpreted to
result from hydrogen ion leakage across the vesicular
membrane.
The £uorescence intensity at 508 nm was con-
verted into the hydrogen ion concentration. A plot
of ln([H]/[H]init) versus time is linear for at least 30
s after the pH jump, suggesting that proton trans-
location is a pseudo-¢rst order process. The plot de-
viates from linearity at later times after the pH jump
due to proton translocation back into the vesicles
through the ionophore. The increase in £uorescence
during the ¢rst 30 s after the pH jump was used to
calculate a leakage rate, assuming a ¢rst order pro-
cess, and ¢rst order rate constants calculated.
To control for vesicle lysis resulting from the pH
jump, in some experiments 5 mM DPX is included in
the pH 8.0 bu¡er. When DPX is included, vesicle
lysis would expose HPTS to the quenching agent,
resulting in a decrease in the observed £uorescence.
The ability of DPX to quench HPTS £uorescence
was con¢rmed by lysing vesicles with 0.1% Triton
X-100. Hydrogen ion leakage without lysis will al-
ways generate an increase in £uorescence [14].
2.3. Binding of squalamine to phospholipid vesicles
Radiolabeled squalamine was used to determine
the amount of squalamine that remained associated
with LUVs after extrusion. Vesicles were prepared
from either PC or PG in the presence of 3H-squal-
amine. After extrusion, the vesicles were separated
from non-vesicular components by a (1U15 cm) Se-
phadex G-75 column. One milliliter fractions were
collected and radioactivity measured by scintillation
counting.
2.4. Contents leakage
The leakage of calcein from LUVs caused by ex-
ternally added aminosterol was measured as previ-
ously described [10]. Squalamine or compound 1
did not a¡ect the entrapment of calcein when added
before vesicle extrusion. Vesicles containing en-
trapped calcein were added to bu¡er (20 mM PIPES,
150 mM NaCl, 1 mM EDTA, pH 7.0) at 30‡C. A
small aliquot of either squalamine (from an aqueous
1 mg/ml stock) or compound 1 (from a 1 mg/ml so-
lution in methanol) was added, and the calcein leak-
Fig. 2. The relationship between the £uorescence intensity of
HPTS (Vex = 469 nm; Vem = 508 nm) and pH. A linear relation-
ship between £uorescence intensity and pH (r2 = 0.98) is ob-
served between pH 7.0 and 8.0.
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age recorded as an increase in £uorescence (Vex = 490
nm; Vem = 520 nm).
3. Results and discussion
3.1. Ionophoric activity of squalamine
The ionophoric activity of squalamine was tested
in extruded LUVs prepared from egg yolk PC, PG
derived from egg yolk PC, POPG, and a PC/PG (7/3)
mixture. Squalamine was incorporated into LUVs by
cosolubilization in organic solvent (2/1 chloroform/
methanol), followed by solvent evaporation and hy-
dration into aqueous bu¡er at pH 7.0. The resuspen-
sion bu¡er contained 0.1 mM HPTS, a pH-sensitive
£uorescent dye whose quantum yield increases with
increasing pH in the 6.5^8.5 pH range. The use of
HPTS as a pH indicator in liposomes was carefully
characterized by Daleke et al. [14]. We used an ex-
citation maximum of 469 nm, which is slightly higher
than the excitation maximum of 450 nm reported by
Daleke et al. [14], and an emission maximum of 508
nm. We ¢nd that the £uorescence of HPTS increased
in a linear fashion as a function of pH between 7.0
and 8.0 (Fig. 2), in agreement with Daleke et al. In
the calculation of proton leakage rates, a linear rela-
tionship between pH and £uorescence was assumed.
Vesicles were prepared by extrusion and external
HPTS separated from entrapped dye by size exclu-
sion chromatography. To test for ionophoric activ-
ity, the vesicles containing entrapped HPTS at pH
7.0 were added to pH 8.0 bu¡er in a £uorescence
cuvette, which was isoosmotic to the bu¡er within
the vesicles. The change in £uorescence was followed
as a function of time, and pseudo-¢rst order rate
constants for proton translocation were calculated.
The ¢rst order rate constants describing the proton
ionophoric activity of squalamine are presented in
Fig. 3. There is no signi¢cant di¡erence in proton
translocation across any of the membranes tested
when squalamine is included in the LUVs at concen-
trations of up to 2 mole%. We conclude that squal-
amine does not act as a proton ionophore under
these conditions.
One possible explanation for the absence of iono-
phoric activity would be the incomplete incorpora-
tion of squalamine into phospholipid vesicles during
extrusion. We have tested the ability of radiolabeled
squalamine to associate with LUVs, and have found
that 100 þ 10% of squalamine added to PG in organ-
ic solvent remains associated with the vesicles after
extrusion. Only 50 þ 10% of radiolabeled squalamine
added to PC in organic solvent remains associated
with PC vesicles after extrusion, while vesicles of
mixed lipid composition were not tested. The lack
of observed ionophoric activity of squalamine in
PG vesicles was not due to loss of squalamine from
the vesicles during preparation.
Regen and co-workers have synthesized an analog
of squalamine (compound 1) which exhibited proton
ionophoric activity [11]. We have synthesized com-
pound 1, prepared LUVs containing the compound,
and tested these for proton translocation. In agree-
ment with previous studies, we ¢nd that compound 1
acts as a proton ionophore in LUVs prepared either
from egg PG or from POPG (Fig. 3). Identical pro-
Fig. 3. The ¢rst order rate constants describing proton translo-
cation across phospholipid membranes as a function of added
aminosterol. Vesicle preparation and aminosterol incorporation
are described in Section 2. The symbol identities are described
in the inset. Open symbols describe experiments carried out
with squalamine, while closed symbols describe experiments car-
ried out with the analog compound 1. PC/PG refers to vesicles
comprised of 70% PC/30% PG (mol/mol). Error bars represent
1 S.D. (n = 3^4). When error bars are not shown, the measured
error is less than the size of the symbol.
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ton translocation rates are obtained in the presence
of the £uorescence quencher DPX in the pH 8.0 bu¡-
er solution. The inaccessibility of HPTS to added
DPX indicates that the change in £uorescence inten-
sity after the pH jump is due to proton transport out
of the vesicles, and not the result of HPTS leakage
from compromised vesicles. Signi¢cant quenching of
HPTS £uorescence by DPX is observed after lysis of
the vesicles with Triton X-100. We also con¢rm the
lack of ionophoric activity of compound 1 when in-
corporated into PC vesicles (data not shown). By
con¢rming the ionophoric activity of the squalamine
analog, we also demonstrate our ability to observe
proton translocation using the HPTS £uorescence
method. Therefore, our inability to observe addition-
al proton translocation in the presence of squalamine
is not due to experimental di⁄culties with the iono-
phore assay.
In our experiments, we have not been able to pre-
pare PG LUVs with a passive proton leakage rate
described by a rate constant of less than 2.0U1034
s31. Regen’s group reports a passive proton perme-
ability in PG vesicles with a ¢rst order rate constant
of less than 1.0U1034 s31 [11]. We have prepared
vesicles from both PG derived from egg PC and
POPG, with approximately the same proton perme-
ability in the absence of incorporated aminosterol.
Our observations are similar to that reported by Ko-
matsu and Chong [15], who have also found that
vesicles prepared from egg PG are more permeable
to protons than vesicles prepared from egg PC. We
see no increase in proton translocation with up to
2 mole% squalamine, while the addition of com-
pound 1 increases the rate constant describing pro-
ton translocation to greater than 10U1034 s31.
Therefore, we are con¢dent that squalamine does
not act as an ionophore in PG vesicles.
An alternative explanation for the results shown in
Fig. 3 is the formation of two populations of vesicles
during lipid extrusion. One population would seques-
ter most if not all of the HPTS, while the second
population would not contain entrapped HPTS.
This possibility is unlikely for the following two rea-
sons. First, vesicles prepared under similar condi-
tions have homogeneous morphology, as character-
ized by scanning electron microscopy [10]. If two
populations of vesicles were formed, the vesicles
would expect to di¡er in size or morphology. Second,
both this study and work previously published by
Regen [11] demonstrate that the proton translocation
rate increases with increasing ionophore concentra-
tion, a relationship not necessarily expected if two
populations of vesicles lead to the £uorescence
changes.
When a mixture of egg PC and egg PG (7/3) is
used, vesicles with low passive proton permeability
can be prepared. Squalamine does not exhibit proton
ionophoric activity in those vesicles. In vesicles pre-
pared from egg PC, the rate constant describing pas-
sive proton leakage is approx. 0.7U1034 s31, similar
to that reported by Regen et al. for the same exper-
imental system [11].
When added to preformed phospholipid vesicles,
squalamine is a potent lytic agent, e¡ecting the re-
lease of entrapped £uorescent dye from LUVs at low
squalamine/phospholipid ratios [10]. The ability of
compound 1 to promote the leakage of calcein
from PG LUVs was tested. The squalamine analog
1, when added at molar ratios of up to 4/1 relative to
vesicle phospholipid, is totally ine¡ective as a lytic
agent (data not shown). Squalamine will e¡ect the
quantitative leakage of calcein from anionic lipid
vesicles at molar ratios of less than 1/1 [10].
To summarize our comparison of the two antimi-
crobial agents, squalamine lyses LUVs but is not
ionophoric while compound 1 acts as a proton ion-
ophore but possesses no lytic activity. In our pre-
vious report, we concluded that the lytic activity of
squalamine was absolutely required for antimicrobial
activity. Since compound 1, which possesses no lytic
activity, is an e¡ective antimicrobial agent, there may
be no relationship between vesicle lysis and antimi-
crobial activity. Our laboratory has synthesized a
wide variety of squalamine analogs [6,7], and we
have begun to test these compounds for lytic activity.
In our initial tests, we ¢nd that several of our ana-
logs exhibit no lytic activity against LUVs prepared
from anionic phospholipid. Therefore, the lytic activ-
ity of squalamine may not be related to its mecha-
nism for antimicrobial activity. However, we do ob-
serve that squalamine will e¡ectively create defects in
bacterial plasma membranes, at squalamine/phos-
pholipid ratios similar to those required to generate
defects in PG LUVs (D.W. Crawford III, B.S. Selin-
sky, manuscript in preparation). This suggests that
bacterial plasma membrane lysis may contribute to
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bacterial cell death, and might at least partially ex-
plain the antimicrobial activity of squalamine.
On the other hand, the ability of some aminoster-
ols to act as proton ionophores must be unrelated to
their antimicrobial activity. Compound 1 will only
act as a proton ionophore when incorporated into
vesicles by co-extrusion with phospholipid. The
same analog added to preformed LUVs neither lyses
the vesicles nor increases the rate of proton trans-
location. Since the antimicrobial activity of the ami-
nosterols is measured by exposing intact bacterial
cells to the antimicrobial agent, the ability of amino-
sterol antibiotics must not be related to ionophoric
activity. The antimicrobial activity of squalamine
must be caused by some other mechanism.
Curiously, when squalamine is incorporated into
PG vesicles during their formation, the resulting
vesicles retain the ability to encapsulate £uorescent
dyes. When added to preformed vesicles at the same
squalamine/phospholipid ratios, squalamine com-
pletely lyses PG vesicles. Squalamine may incorpo-
rate di¡erently into phospholipid vesicles after cosol-
ubilization than when added to preformed vesicles in
aqueous systems. Alternatively, squalamine forms
transient pores when added to preformed phospho-
lipid vesicles, allowing for the leakage of encapsu-
lated £uorescent dyes. The rate of dye leakage is
initially large, but decreases to zero within several
minutes. At low squalamine/phospholipid ratios,
some of the encapsulated dye is retained, and the
vesicles retain the remaining dye for at least several
hours. The reclosure of vesicles compromised with
squalamine suggests that after the initial membrane
insult, squalamine ¢nds an environment in the mem-
branes which does not adversely a¡ect vesicle integ-
rity. During cosolubilization, squalamine may more
easily ¢nd the same position in the membrane, allow-
ing for its presence without membrane destabiliza-
tion.
To summarize, squalamine has been shown to
cause the leakage of the £uorescent dye calcein
from lipid vesicles comprised of either anionic or
zwitterionic phospholipid. Squalamine does not act
as a proton ionophore when incorporated into phos-
pholipid LUVs either when added externally to pre-
formed vesicles or when cosolubilized with lipid dur-
ing vesicle preparation. While squalamine does not
exhibit proton ionophoric activity, the ability of a
di¡erent aminosterol to e¡ect proton translocation
in membranes has been con¢rmed. However, the
ability of some aminosterols to act as proton iono-
phores is likely unrelated to their antimicrobial ac-
tivity.
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